Understanding the versatility of the ExoLiver® platform to study the pathobiology and new therapeutic options for liver diseases.

The study describes the benefits of using the ExoLiver® platform to simulate the human liver sinusoid on a chip.
View full article

More News.

Barcelona Liver Bioservices (BLB) starts operations

Barcelona Liver Bioservices (BLB), a spin-off of IDIBAPS, has been created for the design and development of pre-clinical studies in the fields of hepatology and hepatotoxicity. The co-founders are Jordi Gracia-Sancho, Jaume Bosch and Joan Carles Garcia-Pagan from IDIBAPS and Rosa Villa from CSIC.

Read More »